Application 010379

Type
NDA
Sponsor
KING PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CYTOMELLIOTHYRONINE SODIUMTABLET;ORALEQ 0.005MG BASEYesNo
002CYTOMELLIOTHYRONINE SODIUMTABLET;ORALEQ 0.025MG BASEYesNo
003CYTOMELLIOTHYRONINE SODIUMTABLET;ORALEQ 0.05MG BASEYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N010379-001CYTOMELLIOTHYRONINE SODIUMEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982
N010379-002CYTOMELLIOTHYRONINE SODIUMEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982
N010379-003CYTOMELLIOTHYRONINE SODIUMEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N010379-001AB
N010379-002AB
N010379-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2020-12-22 03:56 UTC2020-12N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 19829b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 19829b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 19823f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 19823f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 1982053a50430f4f…
2023-05-13 08:27 UTC2023-05N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 1982053a50430f4f…
2023-05-13 08:27 UTC2023-05N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N010379-001CYTOMELEQ 0.005MG BASETABLET / ORALABRLD, Approved before 19823bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N010379-002CYTOMELEQ 0.025MG BASETABLET / ORALABRLD, Approved before 19823bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N010379-003CYTOMELEQ 0.05MG BASETABLET / ORALABRLD, Approved before 19823bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N010379-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N010379-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N010379-003AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09N010379-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09N010379-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09N010379-003AB1c2088c7a36db…
2026-09-14 22:38:342026-08N010379-001AB184e616aacf4f…
2026-09-14 22:38:342026-08N010379-002AB184e616aacf4f…
2026-09-14 22:38:342026-08N010379-003AB184e616aacf4f…
2026-08-18 06:07:402026-07N010379-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N010379-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N010379-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N010379-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010379-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N010379-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010379-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010379-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N010379-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N010379-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010379-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N010379-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010379-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010379-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N010379-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010379-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010379-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N010379-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N010379-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N010379-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N010379-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N010379-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N010379-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N010379-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N010379-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N010379-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N010379-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N010379-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N010379-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N010379-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N010379-001AB1d06236e962d9…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Liothyronine SodiumLIOTHYRONINE SODIUMMylan Pharmaceuticals Inc.115a84c2-0126-4dd7-816e-1873875f1e492026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 010379
application number: NDA010379
ndc (product): 59762-1207
ndc (product): 59762-1206
ndc (product): 59762-1208
CytomelLIOTHYRONINE SODIUMPfizer Laboratories Div Pfizer Inc51452b31-ff68-4e0c-b982-c15502ebf1d32026-05-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 010379
application number: NDA010379
ndc (product): 60793-116
ndc (product): 60793-115
ndc (product): 60793-117

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 22 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-0413Cytomelliothyronine sodiumA-S Medication SolutionsNDACurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
60793-115Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-115Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-115Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-116Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-116Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-116Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-117Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-117Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-117Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61576SUPPL2020-01-15
57070SUPPL2018-12-31
57014SUPPL2018-12-26
33015SUPPL2002-05-17
11898SUPPL2002-05-17
217SUPPL2001-09-13